Price movement over the last 24 hours
Cardano vs Bio Protocol — how do they compare? Cardano trades at Rp3,009 (market cap Rp110,15T, Rp6,23T 24h volume), while Bio Protocol trades at Rp497.95 (market cap Rp1,12T, Rp300,59M 24h volume). The key difference: Cardano is far larger — about 98.3× Bio Protocol's market cap, and Cardano's circulating supply is 36,5B / 45B ADA (82%) versus 2,2B / 3,3B BIO (68%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Cardano for 122 Days and Bio Protocol for 16 Days on average.
| ADA | BIO | |
|---|---|---|
Market Cap | Rp110,15T | Rp1,12T |
Volume (24h) | Rp6,23T | Rp300,59M |
Circulating Supply | 36,5B / 45B ADA (82%) | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 122 Days | 16 Days |
Signals from Pluang's Aura AI — not financial advice
Cardano trades at Rp3,002 with a market cap of Rp109.71 trillion, showing neutral technical signals overall. The asset is near key support at Rp2,993 and resistance at Rp3,268, with mixed indicators including a bearish moving average signal but strong ADX readings suggesting trend strength. No major protocol upgrades or ecosystem news were reported recently, keeping fundamental developments quiet.
Outlook remains neutral with opportunities in potential breakout above resistance, but risks include high volatility and regulatory uncertainty. Investors should monitor support levels closely as price hovers in a consolidation zone with balanced buyer and seller pressure.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
What Pluang investors did over the last 30 days
Latest headlines on both assets
A crypto asset known for its proof-of-stake (POS) blockchain. It was first developed by the co-founder of Ethereum in 2015 and launched in 2017. It is also used for the application of smart contracts. This crypto asset is also believed to be the better version of Ethereum.
Read more on ADA →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →